Oncology Intelligence Digest • October 6, 2026 Oncology Intelligence Digest October 6, 2026 One new FDA approval and an ESMO preview lead this edition. Lilly… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here